academic article

• Phase III trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage IIIB/IV non-small-cell lung cancer..  Journal of clinical oncology : official journal of the American Society of Clinical Oncology.  20:1335-1343. 2002
• Second-line, low-dose, weekly paclitaxel in patients with stage IIIB/IV nonsmall cell lung carcinoma who fail first-line chemotherapy with carboplatin plus paclitaxel..  Cancer.  95:1265-1273. 2002